Authors
Kamila Maliszewska-Olejniczak, Michał Fryc, Agata Kustra, Katarzyna Wiktorska, Aleksandra Lenartowicz-Gasik, Wojciech Soroka, Jacek Rzadkiewicz, Monika Żochowska, Bogusz Kulawiak, Piotr Bednarczyk
Published in
Journal of neuro-oncology. Volume 179. Issue 3. Sep 22, 2026. Epub Sep 22, 2026.
Abstract
Large-conductance Ca2 +-activated potassium (BKCa) channels have been implicated in glioblastoma progression and oxidative stress; however, their contribution to the cellular response to ionizing radiation remains poorly understood. Potassium channels represent attractive therapeutic targets because their activity can be modulated pharmacologically using selective inhibitors or genetically by gene silencing (siRNA) or gene knockout (CRISPR/Cas9). Here, we investigated whether genetic inhibition of BKCa modulates the DNA damage response of human glioblastoma cells following electron ultra-high dose rate (UHDR) irradiation.
Human U87MG glioblastoma cells and BKCa-knockout cells (U87MG ΔαBKCa) were exposed to an electron UHDR-9 MeV beam with an average dose rate of 150 Gy/s. Clonogenic survival, reactive oxygen species levels, cell-cycle distribution, apoptosis, DNA-DSBs, DNA repair, and expression of selected genes encoding DDR pathways were analyzed.
BKCa deletion did not significantly alter clonogenic survival following UHDR irradiation. Cells lacking the BKCa channel exhibited elevated ROS levels, altered cell cycle distribution with G0/G1 accumulation, and enhanced apoptosis. UHDR induced lower γH2AX accumulation and reduced 53BP1 foci formation in U87MG ΔαBKCa cells, suggesting impaired DNA damage recognition and repair complex assembly. Gene expression analysis revealed a shift toward upregulation of DSBR pathways and downregulation of PARP-dependent SSBR mechanisms.
In conclusion, these findings identify BKCa as a regulator of the early molecular response of glioblastoma cells to electron UHDR irradiation and provide a basis for further studies investigating BKCa-dependent radiation responses as a target for therapeutic modulation.
PMID:
42773351
Bibliographic data and abstract were imported from PubMed on 23 Sep 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 7
- Comments 0